Extracorporal Photopheresis With UVADEX Plus Standard Steroid Treatment for High Risk Acute Graft-versus-host Disease
Extracorporal Photopheresis With UVADEX Plus Standard Steroid Treatment for High Risk Acute Graft-versus-host Disease
Active, not recruiting · NCT04291261 · Registry updated 2025-03-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Extracorporal Photopheresis With UVADEX Plus Standard Steroid Treatment for High Risk Acute Graft-versus-host Disease | Acute-graft-versus-host Disease | Active, not recruiting | Phase 2 | 2025-03-30 | NCT04291261 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Arbeitskreis Klinische Forschung PD Dr. med. Seiler GmbH | 1 |
| Therakos | 4 |
| University Hospital Regensburg | 17 |
| Universitätsklinikum Hamburg-Eppendorf | 136 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Medical University of Graz, Department of Internal Medicine | Graz | Austria | 1 |
| University Hospital Erlangen | Erlangen | Germany | 9 |
| University Medical Center Hamburg-Eppendorf | Hamburg | Germany | 15 |
| University Medical Center Regensburg | Regensburg | Germany | 1 |